Skip to content

Food Intake and the Adolescent Brain

The Neural Underpinnings of Disinhibited Eating Behavior in Adolescents With and Without Obesity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04208256
Acronym
ADOB
Enrollment
63
Registered
2019-12-23
Start date
2019-12-30
Completion date
2024-09-30
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent, Brain, Feeding Behavior

Keywords

pediatric obesity, resting-state functional magnetic resonance imaging, disinhibited eating behavior

Brief summary

The brain plays an integral role in how and what people eat. However, the brain's contribution to overeating is not well understood during sensitive developmental periods such as adolescence, when excessive weight gain and obesity prevalence are a significant concern.The proposed study will use functional magnetic resonance imaging to examine how the brain's response to excess energy is related to overeating in adolescents with and without obesity.

Interventions

DIETARY_SUPPLEMENTEnergy Stimulus

Energy stimulus (energy surplus v. energy neutral) will be randomly assigned at the first brain imaging visit. At the second brain imaging visit, the participant will receive the alternate stimulus from what they received at the first brain imaging visit.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* male or female * 13-18 years-old * resident of Colorado

Exclusion criteria

* weigh less than 88 pounds or have a BMI% rank of \<10% for age and sex; * have a physician's diagnosis of metabolic syndrome or diabetes (Type 1 or 2); * have a physician's diagnosis of anorexia nervosa or bulimia nervosa; * currently taking anti-psychotic medications (not including anti-depressant or anti- anxiety medications); * have a non-MRI safe device (e.g. pacemaker or defibrillator) or metal in the body (e.g. metal pins, shrapnel); * experience symptoms of claustrophobia when in small or closed-off places; * are pregnant or plan to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Brain functionbrain imaging visit 1 (study visit 1); 30 minutesBrain function will be quantified via the blood oxygen level-dependent (BOLD) signal in the hypothalamus, insula, anterior cingulate cortex, nucleus accumbens, amygdala, and superior and inferior frontal gyri, and connectivity between these brain regions.
Disinhibited eating behaviorstudy visit 2; 1.5 hoursDisinhibited eating behavior will be quantified via the kilocalories consumed during the test meal phase of the Eating in the Absence of Hunger laboratory protocol.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026